Cardiolipin IgM Antibody

Positive cardiolipin IgM means your blood contains IgM antibodies against cardiolipin, an antiphospholipid antibody. It can be transient (for example after infection) or persistently elevated; if confirmed on repeat testing 12 weeks later at medium/high titer, it may indicate antiphospholipid syndrome with increased clotting and pregnancy‑loss risk. It’s not diagnostic alone—discuss follow‑up and management with your clinician.

High cardiolipin antibodies are most often seen with antiphospholipid syndrome and other autoimmune diseases such as systemic lupus erythematosus. They can also rise transiently after infections (syphilis, viral or bacterial), following certain medications or blood transfusion, during pregnancy, and less commonly with malignancy. Persistence versus transient positivity requires follow-up testing to assess clinical risk.

Treatment depends on context. If isolated, repeat testing after ≥12 weeks and control cardiovascular risks; anticoagulation isn’t usually started. For antiphospholipid syndrome with thrombosis, use long‑term anticoagulation (typically warfarin targeting INR 2–3; higher targets or specialist review for recurrent/arterial events); DOACs are generally avoided in high‑risk patients. In pregnancy, give low‑dose aspirin plus prophylactic LMWH; catastrophic APS needs urgent ICU care, steroids, plasmapheresis/IVIG.

Not necessarily—low or single positive anti‑cardiolipin (aCL) can be transient after infection or medication and often isn’t harmful. Concern arises with persistent medium/high titers (confirmed on repeat testing ≥12 weeks) or with clotting, recurrent pregnancy loss, or other antiphospholipid symptoms. If positive, ask your doctor about repeat testing, additional antiphospholipid antibodies, and referral to hematology/rheumatology for assessment.

Anti-cardiolipin antibodies are linked chiefly to antiphospholipid syndrome, characterized by arterial and venous thromboses, recurrent miscarriages, stillbirth, and pregnancy complications (preeclampsia). They are frequently associated with systemic lupus erythematosus and other autoimmune disorders. Transient positivity can occur with infections (e.g., syphilis, HIV, hepatitis) or certain medications, but persistent high titers correlate with thrombotic risk.

A normal anticardiolipin (aCL) antibody level is typically reported as negative when IgG and IgM values are under about 20 units (GPL for IgG, MPL for IgM). Levels 20–40 are considered low‑positive, 40–80 moderate, and >80 high. Reference ranges vary by laboratory and assay, so test-specific cutoffs and clinical context are essential for interpretation.